(Total Views: 397)
Posted On: 05/11/2021 2:56:36 PM
Post# of 153963
Not for vaccine sales -- for sales of OTHER "therapeutics." I put that in quotes because we know that Remdesivir is hardly therapeutic.
Merck and some other big companies have been making big noises about how they are about to have new monoclonal antibody treatments in Phase 2 or 3 (sorry, I don't remember which). The data they are claiming to have thus far looks good.
So, if they can delay therapeutics from small companies (and there are other small companies with other therapeutics that are focused on other things, like actually killing the virus) -- well gee, THEIR drug gets approved first and becomes SOC. Kind of the way Remdesivir did, even though it's not all that good.
But, as they used to say in MAD Magazine, at least it's really expensive.
Merck and some other big companies have been making big noises about how they are about to have new monoclonal antibody treatments in Phase 2 or 3 (sorry, I don't remember which). The data they are claiming to have thus far looks good.
So, if they can delay therapeutics from small companies (and there are other small companies with other therapeutics that are focused on other things, like actually killing the virus) -- well gee, THEIR drug gets approved first and becomes SOC. Kind of the way Remdesivir did, even though it's not all that good.
But, as they used to say in MAD Magazine, at least it's really expensive.
(1)
(0)
